340 likes | 489 Views
CDC Update on the 2007 TB Technical Instructions . Sharmila Shetty, MD Immigrant, Refugee & Migrant Health Branch Division of Global Migration and Quarantine Centers for Disease Control and Prevention. Summary. Overview of Immigrant, Refugee, Migrant Health Branch
E N D
CDC Update on the 2007 TB Technical Instructions Sharmila Shetty, MD Immigrant, Refugee & Migrant Health Branch Division of Global Migration and Quarantine Centers for Disease Control and Prevention
Summary • Overview of Immigrant, Refugee, Migrant Health Branch • Epidemiology and trends of TB in the US • Changes in 2007 TB Technical Instructions (TI)
Annual Estimate of Migrants Entering the U.S. Total: ~60 million Source: U.S. Department of Homeland Security Refugee admissions: 61,498 (2008)
Immigrant, Refugee, and Migrant Health Branch (IRMH) Role • Track and report diseases in these populations • Respond to disease outbreaks in the US and overseas • Advise U.S. partners on health care for refugee groups • Educate and communicate with immigrant and refugee groups and partners. • Provide medical screening and treatment guidelines (technical instructions)
Technical Instructions (TIs) • Consist of medical screening guidelines • Used by overseas panel physicians who conduct medical examinations for U.S.-bound refugees and immigrants • Identify applicants with medical conditions of public health concern
Inadmissible communicable diseases of public health significance • Tuberculosis, active • Syphilis, untreated • Chancroid, untreated • Gonorrhea, untreated • GranulomaInguinale, untreated • LymphogranulomaVenereum, untreated • Hansen’s disease (Leprosy)
Panel Physician Program: Basics • Statistics • 670 panel sites (1 or more panel physicians) • > 1,000 laboratory and radiology facilities • Contracted through Dept. of State • TB=disease of greatest public health concern
Estimated TB Incidence Rate, 2007 Estimated new TB cases (all forms) per 100 000 population No estimate 0-24 25-49 50-99 100-299 300 or more 1/3 of world infected 9.3 million cases of active TB 1.8 million deaths
TB Cases, United States, 1993-2008 TB rate: FB 20.6/100K US 2.1/100K
MDR TB Cases, United States 1993-2007 XDR TB (’00-’06): 76% XDR TB (’00-’06): 76%
Simplified TB Screening Algorithm CDC required TB screening overseas medical exam: panel physicians Normal CXR Abnormal CXR Sputum work-up to identify active TB TB follow-up exam requested + Post-arrival medical exam
1991 Tuberculosis Technical Instructions • CXR if ≥ 15 years old; no screening for <15 yr • If chest x-ray abnormal • Serial AFB smears • If AFB+ • treat until smear negative • complete therapy in US • No cultures, no DST
34% Sensitivity = + AFB Smear Study of 1991 TB TI Culture versus Smears* • 1,179 with CXR suggestive of active TB • TB culture and AFB smears for all • 183 culture positive --Only 63 (34%) smear-positive Conclusion: 1991 protocol missed 66% of culture-positive active TB cases *Maloney SM, et al. Arch Int Med 2006;166:234-40
Hmong Refugee Resettlement, 2004—2005 • 16,000 Laotian Hmong in WatThamKrabok, Thailand • Five states identified 48 TB • Cases (7 MDR) in newly arrived Hmong refugees • TB culture added to screening
TB in US-bound Hmong Refugees • TB Cases *Screened with 1991 TB TI
TB in US-bound Hmong Refugees • TB Cases • TB culture added to screening algorithm
Recommendations • Overseas: Expand screening, treatment, and overall TB control • Focus on high-prevalence countries • Improve TB screening • To include culture • To screen persons <15 years esp. high-prevalence countries • Domestic: Support timely and complete post-arrival follow-up of immigrants and refugees with overseas TB classifications
2007 TB TI • CDC process to revise Technical Instructions began in 2005 • Scientific literature reviewed • Input from U.S. Tuberculosis Community : • Advisory Council for the Elimination of Tuberculosis (ACET) • National Tuberculosis Controllers Association (NTCA) • National Coalition for the Elimination of Tuberculosis (NCET)
2007—TB TI • Chest x-ray for persons ≥15 years of age • and for persons 2-14 years with a TST>10 mm* or positive IGRA • If chest x-ray abnormal, serial AFB smears • and cultures • Drug susceptibility testing (DST) for all TB isolates • Treatment to completion of therapy according to ATS/CDC/IDSA guidelines, delivered as DOT + + • *countries with WHO-estimated incidence rate ≥20 per 100,000
Saint Luke’s Extension Clinic, Philippines FY 2007 (52,530 applicants, 1991 TB TI) vs. FY 2008 (41,793 applicants, 2007 TB TI) TB case detection rate 1991 vs 2007 TB TI: 554 vs. 1,208 (per 100,000)
Implementation • TB culture facilities built -liquid culture w/ Bactec MGIT 960 • Training of panel physicians • Rollout in countries according to: • #s of applicants • TB rates • In-country resources As of January, 2010 • Populations from 27 countries on three continents are being screening according to the 2007 TB TI • 53% immigrants • >50% refugees
Implementation of the 2007 TB TI-Current Status Current status 27 countries 53% of immigrants >50% of refugees
Implementation of the 2007 TB TI-2010 Implementation South Korea Spring Ghana Summer/Fall Nepal Spring Panel physician training India: January 13-15 Ghana: March 16-18 Dominican Republic: May 3-5 ACET/NTCA Vietnam India Summer/Fall Guatemala Summer/Fall Thailand Spring Nigeria Summer/Fall Malaysia Spring Indonesia Summer/Fall
2007 Technical Instructions:Impact on Prevention of Disease • Improve detection of tuberculosis overseas • More refugees that need treatment will receive it • Improve stateside follow-up • Decrease importation of tuberculosis • Assist in global tuberculosis control efforts • Improve tuberculosis expertise and infrastructure overseas
2007 TB Technical Instructions Available at:http://www.cdc.gov/immigrantrefugeehealth/exams/ti/panel/tuberculosis-panel-technical-instructions.html
Acknowledgments • International Organization for Migration (IOM) • Tom O’Rourke • Warren Jones • RazWali • Dr. Yen • Dept. of State • Bureau of Population, Refugees, and Migration • CDC • Drew Posey • Marty Cetron • John Painter • Greg Armstrong • Luis Ortega • Susan Maloney
1991 Tuberculosis Technical Instructions: for applicants ≥15 years of age Signs and symptoms or Valid for travel within 6 months Sputum smears x 3 All (-) (at least one +) Treat until smear negative Noninfectious Class B1 Infectious Class A Class A waiver
2007 TB TI If TB rate ≥20/100,000 2-14 years of age: TST ≥10 mm or Positive IGRA 3 cured HIV Signs and symptoms or + cultures Valid for travel within 6 months Sputum smears x 3 All (-) (at least one +) DOT Treat until smear negative Noninfectious Class B1 Infectious Class A Class A waiver
Waivers for Medical ConditionsBasic Points • IRMH/CDC is involved in the waiver process for immigrants based on the following medical conditions: • HIV Infection • Mental/Physical Disorders with associated harmful behavior • Tuberculosis
Class A Medical Conditions • Inadmissible • Treatment or waiver required for admission • Examples • TB (laboratory positive) • HIV • STIs (untreated) • Mental Disorders with Harmful Behavior (including Alcohol Abuse) • Substance Abuse (no waiver for immigrants)
Class B Medical Conditions • Admissible • Substantial departure from normal health • Examples: • TB (laboratory negative) • STIs (treated), • Mental Disorders without Harmful Behavior • Substance Abuse (in remission) • Stateside notifications for TB